Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | |
| Cash Flows From Operating Activities | |
| Net Income | -54,320 |
| Depreciation Amortization | 93,820 |
| Other Working Capital | -91,310 |
| Other Operating Activity | -23,240 |
| Operating Cash Flow | $-75,050 |
| Cash Flows From Investing Activities | |
| PPE Investments | -22,730 |
| Net Acquisitions | 226,390 |
| Other Investing Activity | 860 |
| Investing Cash Flow | $204,520 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 180,580 |
| Financing Cash Flow | $180,580 |
| Exchange Rate Effect | 6,600 |
| Beginning Cash Position | 102,230 |
| End Cash Position | 418,890 |
| Net Cash Flow | $316,660 |
| Free Cash Flow | |
| Operating Cash Flow | -75,050 |
| Free Cash Flow | -75,050 |